ClinicalTrials.Veeva

Menu

Evaluation of the Efficacy and Safety of Microwave Ablation of Uterine Adenomyosis Under Improved Ultrasound Guidance

P

Peking University Aerospace Centre Hospital

Status

Not yet enrolling

Conditions

Adenomyosis of Uterus

Treatments

Procedure: Peritoneal combined with intrauterine water isolation
Procedure: Peritoneal water isolation

Study type

Interventional

Funder types

Other

Identifiers

NCT06751264
2024-076

Details and patient eligibility

About

This study aims to compare the safety and efficacy of segmental power adjustment combined with uterine cavity hydro-isolation in microwave ablation of adenomyosis

Enrollment

137 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. UFs or AM diagnosed by pathology and ultrasound;
  2. Relevant symptoms such asabnormal uterine bleeding, secondary anemia, progressive dysmenorrhea and enlargement of the uterus;
  3. Voluntarily undergo MWA;
  4. a confirmed available safe transabdominal puncture path;

Exclusion criteria

  1. Pregnancy or malignancy;
  2. Severe and uncorrectable coagulation disorders;
  3. Severe cardiac, liver, and renal dysfunction;
  4. Anesthesia allergy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

137 participants in 2 patient groups

Peritoneal water isolation
Experimental group
Description:
Peritoneal water isolation
Treatment:
Procedure: Peritoneal water isolation
Peritoneal combined with intrauterine water isolation
Experimental group
Description:
Peritoneal combined with intrauterine water isolation
Treatment:
Procedure: Peritoneal combined with intrauterine water isolation

Trial contacts and locations

0

Loading...

Central trial contact

Lei Liang, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems